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Abstract. Background: The effect of general anesthesia on
de~brillation ef~cacy in humans is not known. The purpose
of this study was to determine the effect of general anes-
thesia on the de~brillation energy requirements in patients
undergoing implantation of a pectoral de~brillator.
Methods and Results: Nineteen consecutive patients
who underwent de~brillator implantation under general an-
esthesia were prospectively compared to 16 consecutive
patients who underwent de~brillator implantation by the
same physicians, using similar devices, at another hospital
under conscious sedation. Pre-discharge testing was
performed 1.4 6 1.0 days after implant using sedation in
both groups. The de~brillation energy requirement was de-
termined using the same prede~ned step-down protocol
(15, 10, 8, 5, 3, 1 J) at the time of implantation and during
pre-discharge testing. The clinical characteristics  of the
patients were similar between groups. There was no
signi~cant  difference in the mean implant  de~brillation
energy requirement compared to the mean pre-discharge
de~brillation energy requirement in either the general
anesthesia group (8.5 6 4.7 vs. 8.4 6 3.4 J; p 5 0.9) or in
the conscious sedation group (9.4 6 3.9 vs. 9.0 6 3.8 J; p 5
0.7).
Conclusions: When compared to conscious sedation,
general anesthesia with mechanical ventilation has no
signi~cant effect on de~brillation ef~cacy in patients un-
dergoing de~brillator implantation.
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Nonthoracotomy de~brillator implantation is per-
formed using either general anesthesia or conscious
sedation combined with local anesthesia [1–5]. No
study has determined the independent effect of gen-
eral anesthesia on de~brillation ef~cacy in humans.
Therefore, the purpose of this study was to compare
the effects of general anesthesia and conscious seda-
tion on the de~brillation energy requirements in pa-
tients undergoing implantation of a de~brillator.
Methods
Study design
De~brillators were implanted at one hospital in the
operating room and at another hospital in the electro-
physiology laboratory by the same electrophysiolo-
gists. At the hospital where implants were performed
in the operating room, there was a transition period
after pectoral de~brillators became available, during
which time general anesthesia remained the preferred
approach by the anesthesiologists. At the other hospi-
tal, pectoral de~brillators were implanted using con-
scious sedation combined with local anesthesia in the
electrophysiology laboratory. Pre-discharge de~brilla-
tor testing was performed at both hospitals in the same
fashion in the electrophysiology laboratory using seda-
tion. The different anesthesia practices at the two hos-
pitals allowed a concurrent comparison of the effect of
the two different types of anesthesia on the de~brilla-
tion energy requirement.
Study patients
The study population consisted of 19 consecutive pa-
tients who underwent implantation of a nonthoraco-
tomy de~brillator under general anesthesia at one hos-
pital and 16 consecutive patients who underwent
nonthoracotomy de~brillator implantation under seda-
tion at another hospital during 1997. There were fewer
women in the general anesthesia group compared to
the conscious sedation group (1/19 vs. 5/16; p 5 0.04).
Patients in the general anesthesia  group  tended to
have a higher left ventricular ejection fraction than
patients in the conscious sedation group (0.33 6 0.18
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vs. 0.26 6 0.11, p 5 0.2), but this difference did not
reach statistical signi~cance. Otherwise, there were no
signi~cant differences in the clinical characteristics of
the patients in each group (Table 1).
Implantable de~brillator systems
The  implanted de~brillator systems were  similar in
both groups. Patients underwent placement of a dual-
coil de~brillation lead (Guidant,  Inc.,  St.  Paul, MN;
model 125) via the subclavian or cephalic vein into the
right ventricular apex, and a de~brillator with a bipha-
sic waveform. The de~brillator shell served as a shock-
ing electrode (Guidant, Inc.; models 1742, 1762, and
1763) in each implanted device, except in one patient in
the general anesthesia group (Guidant, Inc.; model
1740) and in one patient in the conscious sedation group
(Guidant, Inc.; model 1741). All devices were implanted
in the left prepectoral region. One patient in the con-
scious sedation group also required placement of a sub-
cutaneous array at the time of implantation because of
elevated de~brillation energy requirements. There
were no implant-related complications.
Testing of de~brillation energy
requirements
A predetermined step-down protocol was used to de-
termine the de~brillation energy requirement, at the
time of implantation and during pre-discharge testing.
Ventricular ~brillation was induced through the device
using 50-Hz ventricular pacing, and the de~brillation
energy requirement was determined by delivering the
following energy steps every 5 minutes: 15, 10, 8, 6, 5,
3, and 1 Joules. The de~brillation energy requirement
was de~ned as the lowest energy that resulted in suc-
cessful de~brillation. Standard waveform polarity was
used initially, where the distal coil is negative, and both
the proximal coil and de~brillator shell are positive. If
15 joules initially failed to de~brillate, then the polarity
was reversed [6–7] and step-down testing began again
at 20 joules. Pre-discharge de~brillator testing  was
performed using the same polarity.
Anesthesia
A combination of different agents was used to achieve
surgical levels of anesthesia in the 19 patients who
underwent implantation under general anesthesia. Af-
ter anesthesia induction, each patient underwent tra-
cheal intubation and mechanical ventilation. Intrave-
nous medications used included diazepam (5 patients;
9.0 6 4.2 mg), midazolam (2 patients; 1.8 6 0.4 mg),
fentanyl (17 patients; 228 6 98 mcg), remifentanil (1
patient; 50 mcg), propofol (2 patients; 135 6 163 mg),
sodium thiopental (7 patients; 288 6 157 mg), etomi-
date (12 patients; 17.5 6 8.0 mg), cisatracurium (13
patients; 15.7 6 9.8 mg), succinylcholine (2 patients;
100 6 0 mg), and pancuronium (3 patients; 6.3 6 1.5
mg). To achieve a balanced anesthetic technique, pa-
tients were also maintained on nitrous oxide (50/50
nitrous oxygen mixture) and/or iso_urane (1 Minimal
Alveolar Concentration). Vasopressors were used as
needed to maintain arterial blood pressure and in-
cluded ephedrine (6 patients; 23 6 18 mg) and phenyle-
phrine (5 patients; 170 6 140 mcg). Supplemental oxy-
gen was administered.
The 16 patients who underwent implantation under
sedation were managed with local anesthesia and con-
scious sedation throughout the procedure. A combina-
tion of 1% lidocaine and 1% bupivacaine was in~ltrated
subcutaneously. Intravenous medications used in-
cluded midazolam (16 patients; 6.3 6 4.1 mg), fentanyl
(15 patients; 177 6 93 mcg), brevital (8 patients; 104 6
43 mg), and propofol (6 patients; 312 6 274 mg). Seda-
tion was deepened brie_y during de~brillation testing.
Sedation during pre-discharge de~brillation energy
requirement testing was performed in the same fash-
ion in each group using a combination of fentanyl (101
6 44 mcg in the general anesthesia group and 105 6 55
mcg in the conscious sedation group) and midazolam
(10.3 6 3.0 mg in the general anesthesia group and 10.1
6 4.8 mg in the conscious sedation group).
Data analysis
All continuous variables were expressed as mean 6
standard deviation. A Student’s t-test was used to com-
pare continuous variables between groups. A paired
t-test was used to compare the de~brillation energy
requirements from implantation to pre-discharge
within each group. The power to detect a difference of
2.5  Joules  within the general anesthesia group was
80%. Chi-square analysis or Fisher’s Exact test was
used to compare nominal variables. A p-value of 0.05
was considered signi~cant.
Results
The results are shown in Table 2. The duration of anes-
thesia at the time of de~brillator implantation was
longer for patients who received general anesthesia
compared to sedation (148 6 40 vs. 119 6 40 mins; p 5
0.04). The time from implantation to pre-discharge




Number 19 16 —
Age (years) 67 6 10 63 6 9 0.3
Male/Female 18/1 11/5 0.04
CAD 68% 69% 1.0
LVEF 0.33 6 0.18 0.26 6 0.11 0.2
Amiodarone 21% 25% 0.8
Abbreviations: CAD, coronary artery disease; LVEF, left ventricular
ejection fraction.
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testing was 1.2 6 0.6 days in the general anesthesia
group compared to  1.5 6 1.3  days in  the conscious
sedation group (p 5 0.4). Patients who received fen-
tanyl in the general anesthesia group received a
signi~cantly higher dose of fentanyl compared to pa-
tients in the conscious sedation group (243 6 78 vs. 177
6 93 mcg; p 5 0.04).
There was no signi~cant difference in the mean im-
plant de~brillation energy requirement compared to
the mean pre-discharge de~brillation energy require-
ment in either the general anesthesia group (8.5 6 4.7
vs. 8.4 6 3.4 J; p 5 0.9) or in the conscious sedation
group (9.4 6 3.9 vs. 9.0 6 3.8 J; p 5 0.7). When patients
who received general anesthesia were compared to
those who received conscious sedation, there was no
difference in the mean implant de~brillation energy
requirement (8.5 6 4.7 vs. 9.4 6 3.9 J; p 5 0.5) or in the
mean pre-discharge de~brillation energy requirement
(8.4 6 3.4 vs. 9.0 6 3.8 J; p 5 0.6).
Discussion
Main ~ndings
The main ~nding of this study is that general anesthe-
sia has no signi~cant effect on the de~brillation energy
requirement in patients undergoing de~brillator im-
plantation, when compared to conscious sedation.
De~brillation energy requirements may change after
implantation due to changes in lead position [8], lead
maturation [9], or changes in clinical status. Studies
that demonstrate no change in de~brillation energy
requirements from the time of implantation to pre-dis-
charge testing [10–11] have not excluded an effect of
anesthesia, because various factors may have opposing
in_uences on the de~brillation energy requirement.
The present study controlled for these other factors so
that the effects of general anesthesia could be evalu-
ated.
Potential anesthetic effects
The ~ndings of this study do not exclude a balanced net
effect of general anesthesia on de~brillation ef~cacy. It
is possible that various factors related to general anes-
thesia have opposing in_uences. The direct hemody-
namic and electrophysiologic effects of many general
anesthetics on the heart [12–13] might have a direct
effect on de~brillation energy requirements. In addi-
tion, vasopressors, which are often required to coun-
teract the vasodilating effects of general anesthetics,
have been shown to increase de~brillation energy re-
quirements in animals [14]. Furthermore, positive-
pressure ventilation might in_uence de~brillation
ef~cacy by changing transthoracic impedance [15].
Changes in transthoracic impedance could have a
greater effect on the de~brillation ef~cacy of active-can
pectoral de~brillators [16], where the de~brillator shell
serves as a subcutaneous electrode.
Prior studies
No prior published study has evaluated the effect of
general anesthesia on de~brillation ef~cacy in humans.
A previous study compared de~brillation ef~cacy using
spring-patch electrodes and monophasic shocks in dogs
with 3 different anesthetic techniques [17]. There were
no differences when pentobarbital was used, compared
to sodium brevital maintained with halothane gas, and
sodium brevital maintained with iso_urane gas. An-
other study in dogs found that de~brillation energy
requirements remained stable over a 10-hour period of
anesthesia with pentobarbital [18].
Animal studies suggest that lidocaine signi~cantly
elevates epicardial de~brillation energy requirements
[19–20]. Lidocaine may increase energy requirements
in a dose-dependent fashion [21], although very high
doses have a minimal effect [22]. The increase in de~b-
rillation energy requirements by lidocaine has also
been demonstrated in humans [23]. However, lidocaine
may have no effect when biphasic waveforms are used
[24]. Furthermore, a recent study in pigs found that
although lidocaine (10 mg/kg/hour) increases the
de~brillation energy requirement by 59% during epi-
cardial de~brillation, it has no effect during endo-
cardial de~brillation [25].
Limitations
The present study did not standardize the general an-
esthesia technique. Because various drug combina-
tions were used, an effect on de~brillation ef~cacy by a
speci~c anesthetic agent cannot be excluded. However,
the purpose of this study was to evaluate the overall
net effects of general anesthesia on de~brillation,
rather than the effects of individual agents.
Another limitation of the study is that there were
fewer women in the general anesthesia group com-
pared to the conscious sedation group. However, the
gender imbalance occurred most likely by chance and
probably did not affect the results of the study [26].
Clinical implications
Although pectoral de~brillators can safely and effec-
tively be implanted by cardiologists in the electro-
Table 2. Results of de~brillation energy requirement testing




Duration of anesthesia (mins) 148 6 40 119 6 40 0.04
Time between testing (days) 1.2 6 0.6 1.5 6 1.3 0.4
Implant DER (J) 8.5 6 4.7 9.4 6 3.9 0.5
Pre-discharge DER (J) 8.4 6 3.4 9.0 6 3.8 0.6
Abbreviations: DER, de~brillation energy requirement; J, Joules;
mins, minutes.
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physiology laboratory using sedation [1–5], many cen-
ters continue to implant de~brillators in the traditional
surgical environment using general anesthesia. This
study demonstrates that when general anesthesia is
used instead of conscious sedation, there is no signi~-
cant effect on de~brillation ef~cacy in patients under-
going pectoral de~brillator implantation. Therefore,
the type of anesthesia used does not affect comparisons
of de~brillation energy requirements between differ-
ent de~brillation systems.
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